Lavenir moléculaire (MOF) présente un parcours remarquable : dun jalon de 20 millions de dollars à la conquête de défis
Molecular Future, A 2017 Dark Horse In 2017, the Molecular Group launched MOF via an Initial Coin Offering (ICO), making waves with its innovative vision and vast potential. MOF secured funding from respected institutions and publicly traded companies, including Collinstar Capital and China Fortune (0110.HK). At the helm was Jason Tso, CEO of the Molecular Group, and the ICO raised over 20,000 Ether, approximately $20 million USD, establishing MOF as a project of significant interest. Exponential Rise and Exchange Traction MOFs journey was characterized by remarkable milestones. Post-ICO, MOF swiftly earned listings on several renowned exchanges, including OKEX, BitFarm, and Bittrex. In the face of a challenging bear market, MOF defied the odds, surging into the global top 30 cryptocurrencies. Its value soared, casting it into the limelight of the altcoin arena, with substantial trading volumes recorded on OKEX. Strategic Capital Operations: A Key to Success A pivotal moment in MOF‘s history was its strategic sale to Australia’s HCASH Foundation at its peak, for nearly tens of millions of dollars USD. The transition ushered in new leadership with Jayden Wei as CEO, Jason Christopher as CTO, and Ryan XU as Chairman of Molecular Future, showcasing the Molecular Groups adept capital operations in the volatile cryptocurrency






